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. . . it is clear that
our patients are
receiving a great
deal of medical
information that is
impacting their
health care decisions
and the manage-
ment they receive.
It will be of in-
creasing importance
for physicians to
stay abreast of
what is being pre-
sented to our pa-
tients so that we
can reinforce the
accurate informa-
tion, rebut any that
is erroneous, and
interpret that
which is equivocal.was scanning a long list of new e-mails recently when one caught my eye. It was
from a VIP patient who had led one of the largest organizations in the State and is
well known and admired for his intellectual accomplishments. The e-mail described
n article he had just read in the magazine Business Week entitled “Do Cholesterol Drugs
o Any Good?” (1). The article, which he thoughtfully attached, correctly assuming
hat I had not read it myself, represented a relatively scholarly, if somewhat one-sided,
resentation of the pros and cons of using statins in patients without overt heart disease.
t quoted authorities and cited literature to argue that the number needed to treat
NNT) for a single patient to benefit was too high for the potential side effects and
xpense of the medication. It alluded to potential conflict of interest on the part of
harmaceutical companies and physician panels, including the U.S. National Cholesterol
ducation Program, who recommend cholesterol reduction with statin therapy. The
-mail indicated that, based on this article, my patient had decided to discontinue his
tatin.
Several days later while driving to work and listening to National Public Radio
NPR), I came upon a program discussing the tendency of physicians to treat the “num-
ers.” They discussed bone density measurements for osteoporosis, glucose levels for dia-
etes, and (of course) cholesterol values for cardiovascular disease as being laboratory
umbers that were often treated by physicians without unequivocal evidence of benefit
nd with some risk of side effects. Again, this was a relatively scholarly presentation
rom a credible source, although clearly a program with a definite viewpoint and agenda.
have no idea how many patients, or potential patients, were influenced to take action
y this program, or even to discuss it with their physician.
These two recent experiences provided a number of thoughts. With regard to my spe-
ific patient, we had a long conversation about the data supporting the benefit of lower-
ng serum cholesterol and the efficacy of statins. We discussed absolute versus relative
isk reduction, an issue addressed in detail in Business Week (1), and the concept of
NT. Among other things, I pointed out to him the many things in every day life that
ncorporate an NNT concept, such as airbags in automobiles. I was impressed at the
evel of sophistication of our discussion, and in the depth of detail involved in determin-
ng how this patient would ultimately be managed.
In a broader sense, however, these experiences stimulated me to think of the medical
nformation available to our patients and how it affects their health care decisions. It is
bvious that there is a large amount of medical information in the print media, on tele-
ision, and especially on the Internet. This can be of great value, informing patients of
eneficial lifestyle choices and empowering them to make intelligent health care deci-
ions. However, the quality and accuracy of the information can vary greatly, from un-
ounded claims to evidence-based and data-driven presentations. The ability of individ-
al patients to understand this information and intelligently incorporate it into their own
ealth care is also very heterogeneous. Some patients have an appropriate background to
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Editor’s Page April 15, 2008:1505–6ully comprehend the information, while others must rely
n interpretation by someone more knowledgeable. Re-
ardless of the nature of the information, or the status of
he patient who receives it, it is clear that our patients are
eceiving a great deal of medical information that is im-
acting their health care decisions and the management
hey receive. It is equally obvious that it is incumbent
pon us as physicians to deal with the transmission of
nformation to patients to prevent harm and ensure that it
s of maximal benefit.
In dealing with this flow of information, it seems ap-
arent that physicians have to be as aware of what is be-
ng presented to our patients. We are all familiar, of
ourse, with the headline stories in the media regarding
reaking trials. We often first learn of these trials through
uestions from our patients, before we have even had a
hance to examine the study results ourselves. However,
here is also a great deal of less sensational information
eing presented to patients, such as the Business Week (1)
nd NPR pieces I discussed. In light of this, I have begun
o scan the media and Internet as much as possible to
eep up with what my patients are reading. While most
f the best informed patients actually bring articles to me
o read, it is a definite advantage to have read and consid-
red the material beforehand. Although this presents a
urden to very busy physicians who are already struggling
o keep up with their medical journals, it makes a favor-
ble impression and is appreciated by the patients.
In an effort to address the issue of medical information
or patients, the American College of Cardiology (ACC)
as initiated a Web site called CardioSmart. Its objective
s to improve outcomes by empowering patients with or
t risk of cardiovascular disease by means of web-based
ducational and informational resources and health man-
gement tools. This program recognizes the need and
esire for patients to have more medical information
vailable to them. It exploits the potential to improve
heir health by providing data to educate patients about
ctions that will be of benefit and those that are detri-
ental. Since all of the information will be evidence
ased and evaluated by experts, CardioSmart will provide
n alternative to sources that offer poorly validated or
rankly erroneous recommendations. Hopefully, Cardio-mart will facilitate our interaction with patients to pur-
ue guideline-based management.
CardioSmart will provide a number of valuable features.
ools will be available for patients to calculate their own
isk of cardiovascular disease. The site will provide objec-
ive updates on breaking health care news stories. A dic-
ionary of cardiovascular terms will be available, as well as
he opportunity for patients to blog and interact with
ach other. A forum entitled “Ask the Cardiologist” will
nable patients to know the answers to some of the most
ommonly asked questions about heart disease. Finally,
ardioSmart will provide a venue for patients to track
nd chart important cardiovascular parameters such as
eart rate, blood pressure, serum chemistries, and so on.
It is now abundantly clear that the transmission of
edical information to the public is of great importance
o physicians. Patients seek this information; it can be of
alue to them in choosing healthy lifestyles and it can
ffect medical decisions. It is important, therefore, that
he information be accurate, unbiased, and understand-
ble. As is true of so many health-related things, we phy-
icians are in the best position to oversee this transmis-
ion of information and to ensure that it is done
ptimally. The ACC has already taken a proactive step in
his direction in initiating CardioSmart, a Web site that
ill be of great value to our patients and to ourselves as
e advise them. It will be of increasing importance for
hysicians to stay abreast of what is being presented to
ur patients so that we can reinforce the accurate infor-
ation, rebut any that is erroneous, and interpret that
hich is equivocal. I’m afraid that Reader’s Digest may
oon be as important to read as JACC for cardiovascular
pecialists.
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